Targeting LL-37-Driven Psoriasiform Inflammation with Apolipoprotein A-I

Psoriasis is a chronic inflammatory skin disease characterized by dysregulated innate and adaptive immune responses. The antimicrobial peptide LL-37 is increased in psoriatic skin and can promote inflammation through effects on cellular damage, leukocyte recruitment, cytokine production, and the formation of immunostimulatory complexes with self-derived nucleic acids. Here, we investigated whether the human plasma protein apolipoprotein A-I (ApoA-I) can regulate LL-37 activity and thereby attenuate psoriasis-associated inflammation. We show that ApoA-I acts as a scavenger of LL-37 and that its administration confers therapeutic benefits in psoriatic skin, as demonstrated in an experimental animal model and human ex vivo models. Mechanistically, ApoA-I limited nucleic acid uptake and TLR-dependent type I interferon responses in plasmacytoid dendritic cells and keratinocytes. In an experimental mouse model, ApoA-I attenuated imiquimod-induced psoriasiform inflammation, reducing clinical, histological, and molecular disease features, while also suppressing inflammatory mediators and psoriasis-associated biomarkers in a human 3D psoriatic skin model. Together, these findings identify ApoA-I as a previously unrecognized regulator of LL-37-driven skin inflammation and suggest that therapeutic strategies aimed at restoring or mimicking ApoA1´s LL-37-scavenging mechanisms may have potential for treatment of psoriasis and related inflammatory skin diseases.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11783966/v1
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Targeting LL-37-Driven Psoriasiform Inflammation with Apolipoprotein A-I

Alicia Wong, Dorota Satała, Maria Rąpała‐Kozik, Dominik A. Kowalczyk et al.
Research Square
Psoriasis: Treatment and Pathogenesis
preprint

Targeting LL-37-Driven Psoriasiform Inflammation with Apolipoprotein A-I

Alicia Wong, Dorota Satała, Maria Rąpała‐Kozik, Dominik A. Kowalczyk, Firdaus Samsudin, Anna Gołda, Karina Adamowicz, Danuta Bryzek, Joanna Kozieł, Artur Schmidtchen, Jan Potempa, Peter Bond
preprint en

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by dysregulated innate and adaptive immune responses. The antimicrobial peptide LL-37 is increased in psoriatic skin and can promote inflammation through effects on cellular damage, leukocyte recruitment, cytokine production, and the formation of immunostimulatory complexes with self-derived nucleic acids. Here, we investigated whether the human plasma protein apolipoprotein A-I (ApoA-I) can regulate LL-37 activity and thereby attenuate psoriasis-associated inflammation. We show that ApoA-I acts as a scavenger of LL-37 and that its administration confers therapeutic benefits in psoriatic skin, as demonstrated in an experimental animal model and human ex vivo models. Mechanistically, ApoA-I limited nucleic acid uptake and TLR-dependent type I interferon responses in plasmacytoid dendritic cells and keratinocytes. In an experimental mouse model, ApoA-I attenuated imiquimod-induced psoriasiform inflammation, reducing clinical, histological, and molecular disease features, while also suppressing inflammatory mediators and psoriasis-associated biomarkers in a human 3D psoriatic skin model. Together, these findings identify ApoA-I as a previously unrecognized regulator of LL-37-driven skin inflammation and suggest that therapeutic strategies aimed at restoring or mimicking ApoA1´s LL-37-scavenging mechanisms may have potential for treatment of psoriasis and related inflammatory skin diseases.

Research Square
Agency for Science, Technology and Research (SG), Jagiellonian University (PL), University of Louisville (US), Bioinformatics Institute (SG)
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon